Peptide de cercetare România | Retatrutide, GHK-Cu, NAD+, Selank, Semax — PEPTIQUE
peptique.ro
LaunchIndex first observed Peptide de cercetare România | Retatrutide, GHK-Cu, NAD+, Selank, Semax — PEPTIQUE (peptique.ro) live on 31 October 2026. View its launch screenshot, category, and verification evidence.

A launch record built from evidence.
Peptide de cercetare România | Retatrutide, GHK-Cu, NAD+, Selank, Semax — PEPTIQUE (peptique.ro) was first observed live on 31 October 2026.
PEPTIQUE offers research-grade peptides (purity ≥99%) sold from a Romania-based depot with next-day shipping; products are for laboratory research use only and not for human consumption.
Its profile is classified as Ecommerce store within Commerce / Retail and ecommerce.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- peptique.ro
- Category
- Commerce / Retail and ecommerce
- Website type
- Ecommerce store
- Observed title
- Peptide de cercetare România | Retatrutide, GHK-Cu, NAD+, Selank, Semax — PEPTIQUE
- Observed description
- Peptide de cercetare cu puritate ≥99%, livrate a doua zi din depozitul din România: Retatrutide 5–30 mg, GHK-Cu, Selank, Semax, NAD+, apă bacteriostatică. Prețuri per flacon, certificat de analiză la cerere. Research use only.
- Detected technologies
- None detected
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 93%
- HTTP status
- 200
A canonical launch profile for peptique.ro.
Share the profile directly or add the optional badge to the website. A badge is never required for inclusion, verification, or ranking.
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.